About us
Ornish Lifestyle Medicine is the first and only program that is scientifically proven to reverse the progression of heart disease. This groundbreaking result - demonstrated by over 35 years of peer-reviewed research from Dr. Dean Ornish - has prompted Medicare and other commercial payers to reimburse for 72 hours of the program under a new benefit category, Intensive Cardiac Rehabilitation. Specifically, the program brings about its transformational impact by helping participants optimize four key areas of their lives: nutrition, group support, exercise, and stress management. Participants make these lifestyle changes within small and consistent groups of people (called cohorts) who understand each other’s health struggles and share each other’s goals for the future. These cohorts are led by unchanging teams of clinicians, who - over the course of 18 four-hour sessions - guide participants through comprehensive lifestyle changes and help them reverse the progression of their heart disease. To learn more about our program, visit us at Ornish.com.
- Website
-
http://www.ornish.com
External link for Ornish Lifestyle Medicine
- Industry
- Wellness and Fitness Services
- Company size
- 51-200 employees
- Headquarters
- Sausalito, CA
- Type
- Partnership
- Founded
- 2011
Locations
-
Primary
900 Bridgeway
Sausalito, CA 94965, US
Employees at Ornish Lifestyle Medicine
-
Deb Kline
-
Anne Ornish
Founder, President, Ornish Lifestyle Medicine
-
Itzel Berrio Hayward
Mindful Communication & Facilitation | Anti-Racist, Trauma-Informed Approach | Creating Inclusive and Equitable Organizations and Communities
-
Dana Forrest RN MSN
Independent Transformative Nurse Coach at Island Oasis Holistic.
Updates
-
Ornish Lifestyle Medicine reposted this
My colleagues and I at leading medical institutions conducted a randomized controlled trial showing, for the first time, that lifestyle medicine, without drugs, may significantly improve cognition and function in many patients with mild cognitive impairment or early Alzheimer’s disease. This study published today in Alzheimer’s Research & Therapy, the leading Alzheimer's peer-reviewed translational research journal. #UnDoAlzheimers